Chapter 69. Henoch-Schonlein Nephritis and Membranoprolifertive Glomerulonephritis

  1. Donald A. Molony MD3,4 and
  2. Jonathan C. Craig MD, PhD5,6
  1. Sharon Phillips Andreoli MD Director1,2

Published Online: 4 MAR 2009

DOI: 10.1002/9781444303391.ch69

Evidence-Based Nephrology

Evidence-Based Nephrology

How to Cite

Andreoli, S. P. (2008) Henoch-Schonlein Nephritis and Membranoprolifertive Glomerulonephritis, in Evidence-Based Nephrology (eds D. A. Molony and J. C. Craig), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444303391.ch69

Editor Information

  1. 3

    Division of Renal Disease and Hypertension, University of Texas, USA

  2. 4

    Houston Medical School, Houston, Texas, USA

  3. 5

    School of Public Health, University of Sydney, Australia

  4. 6

    Department of Nephrology, The Children's Hospital at Westmead, Sydney, Australia

Author Information

  1. 1

    Department of Pediatrics, James Whitcomb Riley Hospital for Children, Indiana University Medical Center, Indianapolis, USA

  2. 2

    Bryon P. and Frances D. Hollett Professor of Pediatrics, Department of Pediatrics, James Whitcomb Riley Hospital for Children, Indiana University Medical Center, Indianapolis, USA

Publication History

  1. Published Online: 4 MAR 2009
  2. Published Print: 5 DEC 2008

ISBN Information

Print ISBN: 9781405139755

Online ISBN: 9781444303391

SEARCH

Keywords:

  • other pediatric renal diseases;
  • Henoch-Schonlein purpura (HSP);
  • etiology, epidemiology, and natural history of HSP nephritis;
  • natural history of HSP nephritis;
  • recommendations for therapy of HSP and HSP nephritis;
  • etiology, epidemiology, and natural history of MPGN;
  • evidence for efficacy of therapies in MPGN;
  • recommendations for therapy of MPGN

Summary

This chapter contains sections titled:

  • Introduction

  • Etiology, epidemiology, and natural history of HSP nephritis

  • Etiology, epidemiology, and natural history of MPGN

  • References